We understand that peptide development is filled with challenges. Due to hydrophilicity, peptides exhibit limited ability to cross physiological barriers and are confronted with efficient hepatic and renal clearance. Also, once inside the systemic circulation, peptides typically have rather short half lives due to aggressive degradation by multiple digestive proteases. These aspects have led to difficult administration routes which resulted to low patient compliance